Nova Patents
AT192898T

Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen.

Abstract

(57) The method and composite for processing the blood for using for the substance aiming at summary in vivo use, especially humans and a blood product, for example, the contaminant contained in blood platelets, are indicated. The contaminant contained in a blood-cells tablet using 8* methoxy プソラレン before long-term preservation and transfusion is deactivated.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

75 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
92647792United States of AmericaA
9306623United States of AmericaW

Members75

Family members, oldest first
DocumentOfficeKind
CA2131168A1CanadaA1
WO9317553A1World Intellectual Property Organization (WIPO)A1
AU3781093AAustraliaA
CA2141803A1CanadaA1
WO9403054A1World Intellectual Property Organization (WIPO)A1
US5288605AUnited States of AmericaA
AU4677993AAustraliaA
WO9427433A1World Intellectual Property Organization (WIPO)A1
AU7243194AAustraliaA
EP0633721A1European Patent Office (EPO)A1
CA2176258A1CanadaA1
WO9512973A1World Intellectual Property Organization (WIPO)A1
EP0653911A1European Patent Office (EPO)A1
AU1172195AAustraliaA
WO9519705A1World Intellectual Property Organization (WIPO)A1
AU1683995AAustraliaA
US5459030AUnited States of AmericaA
AU663939B2AustraliaB2
US5482828AUnited States of AmericaA
JPH08501058AJapanA
AU4220696AAustraliaA
JPH08504174AJapanA
WO9614740A1World Intellectual Property Organization (WIPO)A1
AU4107396AAustraliaA
EP0633721A4European Patent Office (EPO)A4
EP0653911A4European Patent Office (EPO)A4
EP0727938A1European Patent Office (EPO)A1
WO9639815A1World Intellectual Property Organization (WIPO)A1
AU6025596AAustraliaA
US5618662AUnited States of AmericaA
JPH09511152AJapanA
US5709991AUnited States of AmericaA
AU697761B2AustraliaB2
US5908742AUnited States of AmericaA
US5965349AUnited States of AmericaA
EP0727938A4European Patent Office (EPO)A4
EP0653911B1European Patent Office (EPO)B1
EP0633721B1European Patent Office (EPO)B1
AT192898TThis recordAustriaT
AT193418TAustriaT
ATE192898T1AustriaT1
ATE193418T1AustriaT1
DE69328685D1GermanyD1
DE69328777D1GermanyD1
ES2147203T3SpainT3
ES2147752T3SpainT3
DK0653911T3DenmarkT3
DK0633721T3DenmarkT3
PT633721EPortugalE
PT653911EPortugalE
DE69328685T2GermanyT2
DE69328777T2GermanyT2
GR3034068T3GreeceT3
GR3034069T3GreeceT3
US6251580B1United States of AmericaB1
US2001008757A1United States of AmericaA1
CA2176258CCanadaC
US6433343B1United States of AmericaB1
US2003062483A1United States of AmericaA1
US6566046B2United States of AmericaB2
CA2131168CCanadaC
CA2141803CCanadaC
EP0727938B1European Patent Office (EPO)B1
US6586749B2United States of AmericaB2
AT242960TAustriaT
ATE242960T1AustriaT1
DE69432832D1GermanyD1
US2003194806A1United States of AmericaA1
US2004021089A1United States of AmericaA1
JP3502095B2JapanB2
ES2201093T3SpainT3
DE69432832T2GermanyT2
US6866992B2United States of AmericaB2
JP3677287B2JapanB2
US6949753B2United States of AmericaB2